{Reference Type}: Journal Article
{Title}: Glycosylation in the tumor immune response: the bitter side of sweetness.
{Author}: Cao Y;Yi W;Zhu Q;
{Journal}: Acta Biochim Biophys Sin (Shanghai)
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 1
{Factor}: 3.511
{DOI}: 10.3724/abbs.2024107
{Abstract}: Glycosylation is the most structurally diverse form of post-translational modification (PTM) of proteins that affects a myriad of cellular processes. As a pivotal regulator of protein homeostasis, glycosylation notably impacts the function of proteins, spanning from protein localization and stability to protein-protein interactions. Aberrant glycosylation is a hallmark of cancer, and extensive studies have revealed the multifaceted roles of glycosylation in tumor growth, migration, invasion and immune escape Over the past decade, glycosylation has emerged as an immune regulator in the tumor microenvironment (TME). Here, we summarize the intricate interplay between glycosylation and the immune system documented in recent literature, which orchestrates the regulation of the tumor immune response through endogenous lectins, immune checkpoints and the extracellular matrix (ECM) in the TME. In addition, we discuss the latest progress in glycan-based cancer immunotherapy. This review provides a basic understanding of glycosylation in the tumor immune response and a theoretical framework for tumor immunotherapy.